Pancreatic polypeptide, peptide tyrosinetyrosine (PYY), and neuropeptide tyrosine (NPY), three members of a family of structurally related peptides, are mainly expressed in the endocrine pancreas, in endocrine cells of the gut, and in the brain, respectively. In the present study, we have isolated a peptide of the pancreatic polypeptide family from the skin of the South American arboreal frg Phylomedusa bicolor. The primary structure of the peptide was established as Tyr-Pro-Pro-Lys-Pro-Glu-Ser-Pro-Gly-Glu'O-AspAla-Ser-Pro-Glu-Glu-Met-Asn-Lys-Tyr2O-Leu-Thr-Ala-LeuArg-His-Tyr-Be-Asn-Leu3O-Val-Thr-Arg-Gln-Arg-Tyr-NH2. (2) . These peptides generally belong to families of biologically active peptides, which have their counterparts in mammals, such as tachykinins (3, 4), bradykinins (5, 6), angiotensin (7), caerulein/cholecystokinin (8), bombesin/gastrin-releasing peptide (9), opioid peptides (10), antimicrobial peptides (11, 12) , and hypophysiotropic neuropeptides (13, 14) . Although the physiological role of the various peptides synthesized and released by dermatous granular glands remains largely unknown, most of these peptides are produced in such enormous quantities that it is often possible to isolate enough material from a single skin to determine the amino acid sequence (15, 16) .
Arg-His-Tyr-Be-Asn-Leu3O-Val-Thr-Arg-Gln-Arg-Tyr-NH2.
This unusual peptide, named skin peptide tyrosine-tyrosine (SPYY) , exhibits 94% sia with PYY from the frog Rana ridibunda. A synthetic replicate of SPYY inhibits m tpi release from perifused frog neurointermediate lobes in very much the same way as NPY. These results demonstrate the occurrence of a PYY-llke peptide in frog skin. Our data also suggest the existence of a pituitary-skin regulatory loop in amphibians.
The poison glands in the skin of amphibians are an exceptionally rich source of biologically active substances including alkaloids, biogenic amines, and peptides (1). To date, >110 different regulatory peptides have been characterized from amphibian skin extracts (2) . These peptides generally belong to families of biologically active peptides, which have their counterparts in mammals, such as tachykinins (3, 4) , bradykinins (5, 6) , angiotensin (7) , caerulein/cholecystokinin (8) , bombesin/gastrin-releasing peptide (9) , opioid peptides (10) , antimicrobial peptides (11, 12) , and hypophysiotropic neuropeptides (13, 14) . Although the physiological role of the various peptides synthesized and released by dermatous granular glands remains largely unknown, most of these peptides are produced in such enormous quantities that it is often possible to isolate enough material from a single skin to determine the amino acid sequence (15, 16) .
The pancreatic polypeptide (PP) family consists of three members of structurally related peptides, which all possess 36 amino acid residues, exhibit a C-terminal tyrosine amide moiety, and share common features of tertiary structure: (i) PP, originally discovered in the chicken pancreas (17) , is exclusively localized in endocrine cells of pancreatic islets (18) ; (ii) peptide tyrosine-tyrosine (PYY), initially isolated from pig intestine (19) , is primarily synthesized in gut endocrine cells (20) as well as in brainstem neurons (18) ; (iii) neuropeptide tyrosine (NPY), first characterized from the pig brain (21) , is expressed in neurons of the central and peripheral nervous system (22) . Phylogenic studies indicate that NPY and PYY are both present in primitive vertebrates (23) (24) (25) (26) (27) (28) (29) , suggesting that the genes encoding these two peptides arose from early duplication of an ancestral gene (30) . In contrast, PP-like peptide is absent in fish and, therefore, it has been proposed that the PP gene arose from duplication of the PYY gene at the time of emergence of amphibians (30) . The primary structures of all three members of the PP family have recently been determined in the frogs Rana catesbeiana (31) and Rana ridibunda (32, 33) . However, the occurrence of PP-related peptides has never been reported in the skin of amphibians.
We have recently undertaken the purification of a series of unusual polypeptides from the skin of the frog Phyllomedusa bicolor, using their antifungal activity as a biological test (34, 35) . We report here the isolation, characterization, and total synthesis of a 36-residue polypeptide, which shows 94% identity with R. ridibunda PYY (33) . We also show that the synthetic replicate inhibits melanotropin (a-melanocytestimulating hormone, a-MSH) release from frog pars intermedia in very much the same way as NPY (32, 36, 37) . This peptide has been called skin peptide tyrosine-tyrosine (SPYY).
MATERIALS AND METHODS
Purification of SPYY from Frog Skin Extract. The early fractionation steps of the skin extract have been described elsewhere (35) . Briefly, the skin of a specimen of the South American arboreal frog P. bicolor was extracted in 10% acetic acid and chromatographed on a Sephadex G-50 column; aliquots from these fractions were assayed for antifungal activity. Active fractions (fractions 80-90) were subjected to reversed-phase HPLC on a preparative C18 column (RCM 10 x 25) . Fractions that eluted between 62 and 68 min were pooled, freeze dried, and solubilized in 0.5 ml of 20%o acetonitrile/water containing 0.1% trifluoroacetic acid (TFA). An aliquot (50 ,ul) Peptide Synthesis. Peptides were prepared by stepwise solid-phase synthesis using fluoren-9-methoxycarbonyl (Fmoc) polyamide active ester chemistry on a MilliGen model 9050 Pepsynthesizer. All Fmoc amino acids were from MilliGen. 4-Hydroxymethylphenoxyacetic acid (HMP)-linked polyamide/kieselguhr resin and Fmoc amino acid pentafluorophenyl and 3-hydroxy-2,3-dehydro4oxobenzot-riazine esters were from MilliGen/Biosearch. Side-chain protections were t-butyl for tyrosine, serine, and threonine; pentamethylchromansulfonyl (Pmc) for arginine; trityl (Trt) for asparagine and histidine; t-butyloxycarbonyl for lysine; t-butoxy for glutamic acid and aspartic acid. Cleavage of peptidyl resin and side-chain deprotection were carried out at a concentration of 5 mg of peptidyl resin in 1 ml of a mixture composed of TFA, p-cresol, thioanisole, water, and ethyl methyl sulfide (82.5%, 5%, 5%, 5%, and 2.5%; vol/vol) for 2 h at room temperature. After filtering to remove the resin and ether extraction, the crude peptides were purified by a 0 cm 1 0 combination of Sephadex gel filtration, ion-exchange chromatography, and preparative HPLC. Homogeneity of the synthetic peptides was assessed by analytical HPLC, amino acid analysis, solid-phase sequence analysis, and mass spectrometry as described (15) . a-MSH Rease-Inhibiting Activity ofSPYY and SPYY- . The biological activity of SPYY and its C-terminal fragment SPYY-(14-36) was tested on the neurointermediate lobe (NIL) of the frog R. ridibunda. Adult male frogs were purchased from a commercial supplier (Coudtard, St. Hilaire de Riez, France) and housed in a temperature-controlled room (8°C ± 1°C) under an established photoperiod of 12 h of light per day (light on from 06:00 to 18:00 h) for at least 1 week before sacrifice. The frogs were killed by decapitation between 08:00 and 09:00 and the NILs were removed under a microscope. The glands were preincubated for 15 min at room temperature in a Krebs-Ringer solution (15 mM Hepes buffer/112 mM NaCl/2 mM KCl/2 mM CaCl2) supplemented with glucose (2 mg/ml) and bovine serum albumin (0.3 mg/ml). The Krebs-Ringer solution was gassed for 30 min with 02/CO2 (95:5) before use and the pH was adjusted to 7.4.
The perifusion system used to evaluate the effect of SPYY and SPYY-(14-36) on a-MSH release from frog NILs has been described in detail (38) . Briefly, intact NILs were mixed with Bio-Gel P2 beads and transferred into plastic columns (internal diameter, 0.9 cm; three NILs per column). The tissues were perifused with the Krebs-Ringer solution at a constant flow rate (0.3 ml/min) and temperature (28°C) throughout the experiment. The effluent perifusate was collected as 7.5-min fractions during the stabilization period or as 2.5-min fractions during infusion of the peptide solutions. The fractions were immediately chilled on ice until radioimmunoassay. The concentration of a-MSH was measured in each fraction, on the same day as the perifusion experiment, by a double-antibody radioimmunoassay procedure (39) .
The perifusion profiles were calculated and expressed as a percentage of the basal secretory rate. The basal values were calculated as the means offour consecutive fractions (7.5 min each) collected just before the infusion of the peptide solutions. Each figure represents the mean (±SEM) of at least four independent perifusion experiments. column revealed antifungal activity eluting at 4-5 kDa. During the second step of purification of these fractions achieved by HPLC, the initial antifungal activity from the G-50 column was recovered as three distinct active peaks eluting at 41, 64, and 71 min. The latest eluting material exhibiting antifungal activity was identified as a dermaseptinrelated peptide (35) . In the present study, the material eluting at 64 min was further purified. As shown in Fig. 1 , after a series of HPLC runs, a well-separated UV-absorbing peak was obtained that contained a homogeneous peptide (>95% purity as determined by microbore HPLC). Inspection of the near UV spectra of the peak indicated the presence of the classical tyrosine UV signature (Fig. 1 Inset) . This purified peptide (final yield, =100 ug per g oforiginal dry extract) was directly subjected to amino acid sequence analysis.
RESULTS
Amino Acid Sequence Analysis and Mass Spectral Analysis. (40) . As shown in Table 1 , pairwise alignment of the sequences of various PYY-related peptides with that of the newly sequenced peptide revealed high similarity levels ranging between 70%6 and 94% amino acid positional identity.
In particular, the sequence of the peptide most closely resembled that of PYY isolated from the intestine of the frog R. ridibunda (33) on the high level of sequence similarity with these PYYrelated peptides, this peptide was designated skin peptide YY (SPYY).
Solid-Phase Synthesis ofSPYY. A definitive confirmation of the structure proposed for SPYY was obtained through solid-phase synthesis of the peptide by Fmoc methodology. Purification of the synthetic peptide was performed by gel filtration, ion-exchange chromatography, and reversedphase HPLC as described (15) . After purification, synthetic SPYY was shown to be indistinguishable from natural SPYY by the following chemical and physical criteria: (i) HPLC analysis, under both gradient or isocratic conditions, revealed that synthetic SPYY eluted exactly at the same position as the natural peptide (Fig. 1B) ; coinjection of the native and synthetic peptides resulted in only one symmetrical peak. (ii) The sequence of synthetic SPYY could be determined only up to Glul6 by automated Edman degradation after covalent binding of the peptide to a Sequelon arylamine membrane. (iii) Mass spectrometry of a sample of synthetic SPYY gave pseudo-molecular ions [M + nHfl+ at m/z values corresponding to n = 3, 4, and 5 protonated species whose averaged value was 4259.1, identical to that obtained with the natural peptide.
Effect of SPYY and SPYY-(14-36) on a-MSH Release.
Administration of graded doses of synthetic SPYY (5 x 10-1o-10-6 M) induced a dose-related inhibition of a-MSH release from perifused frog NILs (Fig. 3 ). For each dose tested, the maximal inhibitory effect occurred between 25 ** **.* *****..*. **. * .********.******* Pairwise sequence alignments were performed with CLUSTAL v multiple sequence alignment software (40) . A Dayhoff PAM 250 matrix was used in peptide comparisons (41) . Similarity scores were calculated by the method of Wilbur and Lipman (42) . Identical (*) and similar (.) residues among sequences are highlighted. a, Amide. and 30 min after the onset of infusion of SPYY (Fig. 3A) . The effect of SPYY was reversible whatever the dose of the peptide administered, and the basal secretory level was recovered within 60 min after the end of infusion of the peptide solution. Using a series of experiments similar to those presented in Fig. 3A , dose-response curves were established with graded concentrations of SPYY and SPYY-(14-36) (Fig. 3B) . A significant inhibition of a-MSH release was observed after administration of 5 x 10-10 M SPYY. Half-maximal inhibition occurred at a dose of 3.5 x 10-9 M SPYY and 2 x 10-7 M SPYY- . At a dose of 10-7 M, SPYY caused 93% inhibition of a-MSH release.
DISCUSSION
This study presents structural characterization of a member of the PP/NPY/PYY peptide family in the skin of a frog. The sequences of P. bicolor SPYY and R. ridibunda PYY (33) differ by only two amino acid substitutions at positions 7 and 18 . The substitution at position 18 (Thr -* Asn) can be accomplished by the exchange of a single nucleotide in the corresponding cDNA sequence. Conversely, the degree of similarity between the sequences of SPYY on the one hand and frog NPY (32) or PP (31) on the other hand was much lower. The strong similarity of the primary structures of P. bicolor SPYY and R. ridibunda PYY suggests that SPYY may simply correspond to the expression product of the PYY gene in the frog skin. Alternatively, two closely related genes encoding PYY and SPYY, with differential tissue expression, may exist in the genome of P. bicolor as previously demonstrated for brain and skin prothyrotropin-releasing hormone (43, 44) . Structural characterization of PYY from the gut of P. bicolor should help to determine whether SPYY and PYY originate from expression of a single gene.
We have previously shown that, in amphibians, NPY acts as a physiologically important inhibitor of the activity of the pars intermedia of the pituitary (36, 37, 45) . The present data demonstrate that SPYY is also a potent inhibitor of a-MSH secretion in vitro. Since the C-terminal peptide SPYY-(14-36) was capable of inhibiting a-MSH release (although this short-chain analog was less potent than SPYY), it appears that the action of SPYY is likely mediated through Y2 receptors (46) . Thyrotropin-releasing hormone, another peptide produced by frog skin (43) , is also involved in the control of a-MSH release from the pars intermedia (38, 47) . The fact that dermal melanocytes are the main target cells for a-MSH, together with the occurrence of thyrotropin-releasing hormone and SPYY in frog skin, suggests the existence of a regulatory loop between the pars intermedia of the pituitary and the skin in amphibians.
The isolation in the skin of P. bicolor of a peptide from the PP/NPY/PYY family validates the concept of the potential use of frog skin for identification of specific regulatory peptides (48) (49) (50) . The skin of amphibians contains both a rich variety and large amounts of biologically active peptides. For instance, in the present study, SPYY was purified from the skin of a single specimen (-1 g), while the related peptides NPY and PYY have previously been isolated from 1200 brains (=95 g) and 400 intestines (==270 g) ofR. ridibunda (32, 33) . The huge concentration of peptides stored in amphibian skin has already allowed the identification of 110 peptides including hormones, neuropeptides, and defensive peptides (10, 11, 51) . As a result, frog skin proves to be a very useful organ for characterization of peptides and for elucidation of their biosynthetic pathways. 
